- Home
- IBTA vs KMTS Comparison
IBTA vs KMTS Comparison
Compare IBTA & KMTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IBTA
- KMTS
- Stock Information
- Founded
- IBTA 2011
- KMTS 2014
- Country
- IBTA United States
- KMTS United States
- Employees
- IBTA N/A
- KMTS N/A
- Industry
- IBTA
- KMTS
- Sector
- IBTA
- KMTS
- Exchange
- IBTA Nasdaq
- KMTS NYSE
- Market Cap
- IBTA 1.1B
- KMTS 1.0B
- IPO Year
- IBTA 2024
- KMTS 2025
- Fundamental
- Price
- IBTA $38.35
- KMTS $15.03
- Analyst Decision
- IBTA Buy
- KMTS Buy
- Analyst Count
- IBTA 10
- KMTS 5
- Target Price
- IBTA $74.60
- KMTS $27.00
- AVG Volume (30 Days)
- IBTA 313.1K
- KMTS 156.9K
- Earning Date
- IBTA 08-12-2025
- KMTS 07-13-2025
- Dividend Yield
- IBTA N/A
- KMTS N/A
- EPS Growth
- IBTA 24.66
- KMTS N/A
- EPS
- IBTA 2.03
- KMTS N/A
- Revenue
- IBTA $369,501,000.00
- KMTS $52,636,000.00
- Revenue This Year
- IBTA $6.77
- KMTS $113.57
- Revenue Next Year
- IBTA $15.05
- KMTS $42.47
- P/E Ratio
- IBTA $18.86
- KMTS N/A
- Revenue Growth
- IBTA 7.20
- KMTS 589.86
- 52 Week Low
- IBTA $31.40
- KMTS $14.15
- 52 Week High
- IBTA $79.80
- KMTS $26.15
- Technical
- Relative Strength Index (RSI)
- IBTA N/A
- KMTS N/A
- Support Level
- IBTA N/A
- KMTS N/A
- Resistance Level
- IBTA N/A
- KMTS N/A
- Average True Range (ATR)
- IBTA 0.00
- KMTS 0.00
- MACD
- IBTA 0.00
- KMTS 0.00
- Stochastic Oscillator
- IBTA 0.00
- KMTS 0.00
About IBTA Ibotta Inc. Class A Common Stock
Ibotta Inc is a performance marketing platform. It allows CPG brands to deliver digital promotions to consumers through a single, convenient network called the Ibotta Performance Network (IPN).
About KMTS KESTRA MEDICAL TECHNOLOGIES LTD
Kestra Medical Technologies Ltd is a commercial-stage, wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. It has developed and is commercializing its Cardiac Recovery System platform, a comprehensive and developed system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution. The cornerstone of its Cardiac Recovery System platform is the ASSURE WCD, a next-generation wearable cardioverter defibrillator (WCD) used to protect patients at an elevated risk of sudden cardiac arrest (SCA), a prominent public health problem.